Candide solution for topical application 1% bottle with dropper cap 15 ml No. 1

Instructions Candide solution for topical application 1% bottle with dropper cap 15 ml No. 1

Composition

active ingredient: clotrimazole;

1 ml of solution contains clotrimazole 10 mg;

excipients: propylene glycol, glycerin.

Dosage form

Oral solution.

Main physicochemical properties: transparent, viscous, colorless liquid.

Pharmacotherapeutic group

Means for use in dentistry.

Antimicrobial and antiseptic agents for topical use.

ATX code A01A B18.

Pharmacological properties

Pharmacodynamics

The pharmacological action of Candida is due to the properties of clotrimazole, which is part of its composition. Clotrimazole is a broad-spectrum antifungal agent from the group of imidazole derivatives. Dermatophytes, yeast fungi, and mold fungi are sensitive to clotrimazole.
The effect of clotrimazole is associated with a disruption of the synthesis of ergosterol, which is part of the cell membrane of fungi, as a result of which the structure and properties of the membranes change, and cell lysis is observed.

When applied topically, only small amounts of clotrimazole are absorbed into the bloodstream, so there are no systemic effects.

Pharmacokinetics

When applied topically, only small amounts of clotrimazole are absorbed into the bloodstream, so there are no systemic effects.

Indication

Local treatment of oral candidiasis. Pharyngomycosis.

Contraindication

Hypersensitivity to clotrimazole or to other components of the drug, including propylene glycol and glycerin.

Interaction with other medicinal products and other types of interactions

Data is missing.

Application features

The drug is not intended for oral administration, so it should not be swallowed when used.

Prevent the drug from getting into the eyes.

In some cases, bacterial resistance to clotrimazole has been observed. In the absence of a therapeutic effect of the drug, another method of treatment should be used.

Ability to influence reaction speed when driving vehicles or other mechanisms

Does not affect.

Use during pregnancy or breastfeeding

The safety of the drug in this category of patients has not been established. The drug should be avoided in the first trimester of pregnancy.

Method of administration and doses

Apply 10-20 drops of Candida to the affected areas of the oral mucosa using a cotton swab 3-4 times a day. All affected areas of the oral mucosa should be treated with the drug. Usually, a positive result from the application is observed on the 3-5th day of treatment, however, in some cases, treatment may be continued until the signs of infection disappear completely. During and after treatment, special attention should be paid to eliminating any influences that may lead to the return of the infection.
The course of treatment is determined by the doctor.

Children

There is insufficient data on the use of the drug in children.

Overdose

With the recommended regimen, the occurrence of overdose symptoms is impossible.

Adverse reactions

Allergic reactions are possible. Pain and irritation at the application site.

Fainting, hypotension, shortness of breath, skin rash, urticaria, erythema, burning, tingling, itching, edema, contact dermatitis may occur.

Expiration date

3 years.

Storage conditions

Store in a place protected from light at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging

15 ml of the drug in bottles with a dropper stopper and a cap with first-open control, 1 bottle in a cardboard box.

Vacation category

Without a prescription.

Producer

Glenmark Pharmaceuticals Ltd./Glenmark Pharmaceuticals Ltd.

Location of the manufacturer and its business address

Plot No. E-37/39, MIDC, Industrial Estate, Satpur, Nasik – 422 007, India.